Novo Nordisk A/S
XHAM:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
XHAM:NOV
|
DK |
|
M
|
Moody's Corp
XBER:DUT
|
US |
|
M
|
Mitsubishi Estate Co Ltd
XMUN:MES
|
JP |
|
Schoeller Bleckmann Oilfield Equipment AG
OTC:SBOEY
|
AT |
|
Cantor Equity Partners Inc
NASDAQ:CEP
|
US |
|
N
|
National Beverage Corp
SWB:20V
|
US |
|
S
|
Swatch Group AG
DUS:UHR
|
CH |
|
T
|
Trane Technologies PLC
F:2IS
|
IE |
|
I
|
Industria de Diseno Textil SA
WSE:ITX
|
ES |
|
Saturn Oil & Gas Inc
TSX:SOIL
|
CA |
|
F
|
Fluent Inc
F:7TM
|
US |
Wall St Price Targets
NOV Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for
NOV is 43.35 EUR with a low forecast of 26.72 EUR and a high forecast of 63.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOV's stock price target?
Price Target
43.35
EUR
According to Wall Street analysts, the average 1-year price target for
NOV is 43.35 EUR with a low forecast of 26.72 EUR and a high forecast of 63.05 EUR.